HomeCompaniesPharmanovia (Atnahs Pharma UK Limited)
Company
Pharmanovia (Atnahs Pharma UK Limited)
UK-headquartered specialty pharmaceutical company that relicenses and relaunches established medicines; in-licensed catumaxomab from Lindis Biotech in November 2024 and won Korjuny's first EU authorisation in February 2025.
1 story
Regulatory News has published 1 story about Pharmanovia (Atnahs Pharma UK Limited) on 8 October 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 8 October 2026.
This page is generated from Regulatory News’ editorial coverage of Pharmanovia (Atnahs Pharma UK Limited). It is not an advertisement.
Products in our coverage
Our coverage
